Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity (Q49144853)

18 February 2018

http://europepmc.org/abstract/MED/27768254

title

Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity. (English)

1 reference

18 February 2018

http://europepmc.org/abstract/MED/27768254

0 references

1 reference

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Anja Geerts

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

13

Jean-Marc Kaufman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

14

Bruno Lapauw

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

10

Anne Hoorens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Frederique Van de Velde

4

object named as

Frederique Van de Velde

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Marlies Bekaert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

D Margriet Ouwens

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Tina Hörbelt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Pia Fahlbusch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Daniella Herzfeld de Wiza

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Yves Van Nieuwenhove

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Patrick Calders

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Marleen Praet

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

21 October 2016

1 reference

18 February 2018

http://europepmc.org/abstract/MED/27768254

published in

Obesity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

2544-2552

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Histopathology of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Adipokines as novel biomarkers and regulators of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

CCR2 promotes hepatic fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Wnt'er in liver: expression of Wnt and frizzled genes in mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Adipokines in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Adipocytokines and hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Omentin plasma levels and gene expression are decreased in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FOBY.21674

21 January 2018

Identifiers

DOI

10.1002/OBY.21674

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27768254%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference